CompaniesImmix Biopharma

Immix Biopharma

active
Los Angeles, CA, United States
Founded 2012
Website
About

Small Molecules

Areas of Focus

Categories

NanotechSmall Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

100

By Phase

PHASE1/PHASE2: 2

By Status

RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
Today
NCT06097832
Hover over trial bars to see details

Recent Trials

NCT06097832Collaborator
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis
PHASE1/PHASE2Recruiting
40 participants
Started: Jun 5, 2024 · Completed: Jan 31, 2039
NCT05840835Lead Sponsor
Study of IMX-110 in Combination With Tislelizumab in Patients With Advanced Solid Tumors
PHASE1/PHASE2Unknown
60 participants
Started: Feb 3, 2023 · Completed: Jan 24, 2024
Locations (1)
Headquarters
Los Angeles, CA, United States
Map

Loading map...